Skip to main content

CVE detail

CVE-2026-24064

Waves Central for macOS versions 13.0.9 through 16.5.5 contain a local privilege escalation vulnerability. A trusted XPC client component included with the product is signed with hardened runtime entitlements that permit dynamic library injection. A local attacker can set the DYLD_INSERT_LIBRARIES environment variable to inject an attacker-controlled dynamic library into the trusted client process at launch. The injected code runs within the signed process and can connect to the product's privileged helper service to invoke privileged operations, resulting in arbitrary code execution as root. The issue is fixed in version 16.6.2.

CVSS 7.8 · HighBuzz score 11.9

Buzz score

Why this CVE is surfacing

Buzz score total 11.9

This all-time snapshot uses the same composite formula as Trending across a 30-year evidence window, rather than a current rolling window.

Buzz score components · mention 6.9 · diversity 5.0 · KEV 0.0 · OTX 0.0 · PoC 0.0
Mention score
6.9
1 evidence mentions in the snapshot
Diversity score
5.0
1 sources across 1 categories
KEV score
0.0
No KEV entry observed
OTX score
0.0
0 OTX pulses
PoC score
0.0
0 repos · best confidence N/A
Best PoC traction
0
Maximum stars on a matched PoC repo

Why it matters now

Mention timeline

Total mentions
0
within the 30d window
Peak daily
0
highest bucket

Evidence

Source links by recency

Newest mentions first
1 source links · newest first
  • https://r.sec-consult.com/wavesr.sec-consult.com

    No excerpt available.

    Third Party Advisoryr.sec-consult.comJun 9, 2026, 4:16 PM

Exploit code

Public exploit repository references

Public PoC repositories are third-party, potentially unsafe artifacts. Treat their code as untrusted and use it only on authorized systems in an isolated, least-privilege environment. cvebuzz does not execute the code or verify that an exploit works.

0 repository references · best confidence N/A · max 0 stars
No public PoC repositories have been matched yet.

Related records

Similar CVEs

6 related CVEs with shared weakness or product evidence